Latest Breaking News On - Vp global communications european investor relations - Page 4 : comparemela.com

Valneva Shareholders Approve EGM Resolutions Including the Transition to a Board of Directors

Valneva Shareholders Approve EGM Resolutions Including the Transition to a Board of Directors
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

James sulatKathrin jansenFrederic jacototFranck grimaudJames connollyAnne marie graffinDipal patelThomas lingelbachSanofi pasteurVincent dequenneJuan carlos jaramilloJoshua drummVp global communications european investor relationsEuronext parisManagement boardExtraordinary general meeting

Valneva Shareholders Approve EGM Resolutions Including the Transition to a Board of Directors

Valneva Shareholders Approve EGM Resolutions Including the Transition to a Board of Directors
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Juan carlos jaramilloJames connollyAnne marie graffinJames sulatVincent dequenneDipal patelFranck grimaudKathrin jansenSanofi pasteurThomas lingelbachFrederic jacototJoshua drummVp global communications european investor relationsMarie graffinEuronext parisManagement board

Valneva Reports Positive 24-Month Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

Valneva Reports Positive 24-Month Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJuan carlos jaramilloJoshua drummCenters for diseaseOxford university pressHealth canadaHealth information for internationalVp global communications european investor relationsOxford universityReports positiveMonth antibody persistence dataSingle shot chikungunya vaccineEuronext parisAdverse eventSpecial interest

Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15

Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15 9,437 participants enrolled at sites across the U.S., Europe and Canada in areas where Lyme.

New yorkUnited statesJoshua drummAnnaliesa andersonJuan carlos jaramilloLyme borreliosisNational surveillance systemsHead vaccine researchEuropean medicines agencyCenters for diseaseDrug administrationPfizer incPfizer announce collaboration to coVp global communications european investor relationsExchange commissionValneva complete recruitment

Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15

Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkJuan carlos jaramilloLyme borreliosisAnnaliesa andersonJoshua drummHead vaccine researchCenters for diseaseNational surveillance systemsDrug administrationVp global communications european investor relationsEuropean medicines agencyPfizer incExchange commissionPfizer announce collaboration to coValneva complete recruitment